Exact Mass: 396.03624560000003
Exact Mass Matches: 396.03624560000003
Found 191 metabolites which its exact mass value is equals to given mass value 396.03624560000003
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Sucralose
C12H19Cl3O8 (396.01454640000003)
Sucralose is a noncalorific sweetener with good taste properties One report suggests sucralose is a possible trigger for some migraine patients. Another study published in the Journal of Mutation Research linked doses of sucralose equivalent to 11,450 packets per day in a person to DNA damage in mice. Results from over 100 animal and clinical studies in the FDA approval process unanimously indicated a lack of risk associated with sucralose intake. However, some adverse effects were seen at doses that significantly exceeded the estimated daily intake (EDI), which is 1.1 mg/kg/day. When the EDI is compared to the intake at which adverse effects are seen, known as the highest no adverse effects limit (HNEL), at 1500 mg/kg/day, there is a large margin of safety. The bulk of sucralose ingested is not absorbed by the gastrointestinal (GI) tract and is directly excreted in the feces, while 11-27\\% of it is absorbed. The amount that is absorbed from the GI tract is largely removed from the blood stream by the kidneys and eliminated in the urine with 20-30\\% of the absorbed sucralose being metabolized. Sucralose belongs to a class of compounds known as organochlorides (or chlorocarbons). Some organochlorides, particularly those that accumulate in fatty tissues, are toxic to plants or animals, including humans. Sucralose, however, is not known to be toxic in small quantities and is extremely insoluble in fat; it cannot accumulate in fat like chlorinated hydrocarbons. In addition, sucralose does not break down or dechlorinate. Sucralose can be found in more than 4,500 food and beverage products. It is used because it is a no-calorie sweetener, does not promote dental caries, and is safe for consumption by diabetics. Sucralose is used as a replacement for, or in combination with, other artificial or natural sweeteners such as aspartame, acesulfame potassium or high-fructose corn syrup. Sucralose is used in products such as candy, breakfast bars and soft drinks. It is also used in canned fruits wherein water and sucralose take the place of much higher calorie corn syrup based additives. Sucralose mixed with maltodextrin or dextrose (both made from corn) as bulking agents is sold internationally by McNeil Nutritionals under the Splenda brand name. In the United States and Canada, this blend is increasingly found in restaurants, including McDonalds, Tim Hortons and Starbucks, in yellow packets, in contrast to the blue packets commonly used by aspartame and the pink packets used by those containing saccharin sweeteners; though in Canada yellow packets are also associated with the SugarTwin brand of cyclamate sweetener. Sucralose is a highly heat-stable artificial sweetener, allowing it to be used in many recipes with little or no sugar. Sucralose is available in a granulated form that allows for same-volume substitution with sugar. This mix of granulated sucralose includes fillers, all of which rapidly dissolve in liquids.[citation needed] Unlike sucrose which dissolves to a clear state, sucralose suspension in clear liquids such as water results in a cloudy state. For example, gelatin and fruit preserves made with sucrose have a satiny, near jewel-like appearance, whereas the same products made with sucralose (whether cooked or not) appear translucent and marginally glistening.[citation needed] While the granulated sucralose provides apparent volume-for-volume sweetness, the texture in baked products may be noticeably different. Sucralose is non-hygroscopic, meaning it does not attract moisture, which can lead to baked goods that are noticeably drier and manifesting a less dense texture than baked products made with sucrose. Unlike sucrose which melts when baked at high temperatures, sucralose maintains its granular structure when subjected to dry, high heat (e.g., in a 350 ¬?F (177 ¬?C) oven). Thus, in some baking recipes, such as burnt cream, which require sugar sprinkled on top to partially or fully melt and crystallize, substituting sucr... D000074385 - Food Ingredients > D005503 - Food Additives D010592 - Pharmaceutic Aids > D005421 - Flavoring Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 703
Cefalotin
Cefalotin is only found in individuals that have used or taken this drug. It is a cephalosporin antibiotic.The bactericidal activity of cefalotin results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). The PBPs are transpeptidases which are vital in peptidoglycan biosynthesis. Therefore, their inhibition prevents this vital cell wall compenent from being properly synthesized. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Sulconazole
C18H15Cl3N2S (396.00214800000003)
D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AC - Imidazole and triazole derivatives D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent
Nitrovin hydrochloride
C14H13ClN6O6 (396.05850680000003)
methyl (1R,2S)-2,5,7-trihydroxy-2-methyl-4,6,11-trioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
4H-Thieno(2,3-b)thiopyran-2-sulfonamide, 5,6-dihydro-6-(3-methoxypropyl)-4-(propylamino)-, 7,7-dioxide, (4S,6S)-
Persicarin
Persicarin is a member of the class of compounds known as 3-sulfated flavonoids. 3-sulfated flavonoids are flavonoids that are sulfated at the 3-ring position of the flavonoid skeleton. Thus, persicarin is considered to be a flavonoid lipid molecule. Persicarin is practically insoluble (in water) and an extremely strong acidic compound (based on its pKa). Persicarin can be found in dill, which makes persicarin a potential biomarker for the consumption of this food product.
TIIAS
C19H17O6S-.Na+ (396.06435020000004)
3,5,6-Trimethoxy-3,4-methylene-dioxyfurano[2,3:7,8]flavone
N-{[5-(2-Thienyl)-2-thienylcarbonyl]oxy}-3-(trifluoromethyl)benzenecarboximidamide
C17H11F3N2O2S2 (396.02140219999995)
Me ester,di-Ac-3,8-Dihydroxy-1-methylanthraquinone-2-carboxylic acid
[4-(5,7-diacetyloxy-4-oxochromen-3-yl)phenyl] acetate
(2S,6R)-7-Brom-4,6,2-trimethoxy-6-methyl-spiro[benzofuran-2,1-cyclohex-2-en]-3,4-dion|(2S,6R)-7-bromo-4,6,2-trimethoxy-6-methyl-spiro[benzofuran-2,1-cyclohex-2-ene]-3,4-dione
(2R,3S,4R,5S,6S,7R)- 2,3,5,6,7-pentachloropentadec-14-en-4-ol
C15H25Cl5O (396.03479500000003)
(2R,3S)-2-(3,4-dihydroxyphenyl)-3,5,9,10-tetrahydroxy-2,3-trans-3,4-dihydro-2H-benzofurano[2,3-h]chromene|gambircatechol
6,8-dimethoxy-7-(6?-methoxy-7?-coumarinyloxy)coumarin
3,4-dimetoxyphenyl 1-O-beta-(6-sulpho)-glucopyranoside
3-(1-Oxo-3-hydroxy-2-butenyl)-4,5-dihydroxy-9,10-dihydro-9,10-dioxoanthracene-2-acetic acid methyl ester
dehydrochebulic acid trimethyl ester|Trimethyl ester dehydrochebulic acid
1,4,5-Triacetoxy-2-methyl-anthrachinon|1,4,5-triacetoxy-2-methyl-anthraquinone|islandicin peracetate|islandicin triacetate|Islandicintriacetat|Islanelicintriacetat|Tri-Ac-1,4,5-Trihydroxy-2-methylanthraquinone|Tri-O-acetyl-islandicin
TIIAS
C19H17NaO6S (396.06435020000004)
4-Demethyldehydropodophyllotoxin
Sucralose
C12H19Cl3O8 (396.01454640000003)
D000074385 - Food Ingredients > D005503 - Food Additives D010592 - Pharmaceutic Aids > D005421 - Flavoring Agents CONFIDENCE Reference Standard (Level 1)
Flucarbazone
CONFIDENCE standard compound; INTERNAL_ID 147; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3500; ORIGINAL_PRECURSOR_SCAN_NO 3498 CONFIDENCE standard compound; INTERNAL_ID 147; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3490; ORIGINAL_PRECURSOR_SCAN_NO 3488 CONFIDENCE standard compound; INTERNAL_ID 147; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3481; ORIGINAL_PRECURSOR_SCAN_NO 3477 CONFIDENCE standard compound; INTERNAL_ID 147; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3485; ORIGINAL_PRECURSOR_SCAN_NO 3481 CONFIDENCE standard compound; INTERNAL_ID 147; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3482; ORIGINAL_PRECURSOR_SCAN_NO 3480 CONFIDENCE standard compound; INTERNAL_ID 147; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3483; ORIGINAL_PRECURSOR_SCAN_NO 3481 CONFIDENCE standard compound; INTERNAL_ID 147; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7700; ORIGINAL_PRECURSOR_SCAN_NO 7699 CONFIDENCE standard compound; INTERNAL_ID 147; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7696; ORIGINAL_PRECURSOR_SCAN_NO 7694 CONFIDENCE standard compound; INTERNAL_ID 147; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7709; ORIGINAL_PRECURSOR_SCAN_NO 7707 CONFIDENCE standard compound; INTERNAL_ID 147; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7721; ORIGINAL_PRECURSOR_SCAN_NO 7719 CONFIDENCE standard compound; INTERNAL_ID 147; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7744; ORIGINAL_PRECURSOR_SCAN_NO 7742 CONFIDENCE standard compound; INTERNAL_ID 147; DATASET 20200303_ENTACT_RP_MIX500; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7710; ORIGINAL_PRECURSOR_SCAN_NO 7708
Cys Cys Asp Gly
Cys Cys Gly Asp
Cys Asp Cys Gly
Cys Asp Gly Cys
Cys Gly Cys Asp
Cys Gly Asp Cys
Asp Cys Cys Gly
Asp Cys Gly Cys
Asp Gly Cys Cys
Gly Cys Cys Asp
Gly Cys Asp Cys
Gly Asp Cys Cys
Ethyl 4-acetoxy-8-bromo-5,6-dimethoxy-2-naphthoate
5-BROMO-3-(1-(ETHYLSULFONYL)PIPERIDIN-4-YL)-1H-INDAZOLE-7-CARBONITRILE
3-amino-N-[3-oxo-2-(2,4,6-trichlorophenyl)-1H-pyrazol-5-yl]benzamide
C16H11Cl3N4O2 (395.99475559999996)
3-Amino-N-(5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl)benzamide
C16H11Cl3N4O2 (395.99475559999996)
Methyl 4-acetoxy-7-bromo-5,8-dimethoxy-6-methyl-2-naphthoate
Methyl 5-acetoxy-7-bromo-4,8-dimethoxy-6-methyl-2-naphthoate
6-Iodo-1-(4-methoxybenzyl)-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one
7-Iodo-1-(4-methoxybenzyl)-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one
(4,5-diacetyloxy-9,10-dioxoanthracen-2-yl)methyl acetate
(Cyclopropylmethyl)(triphenyl)phosphonium bromide
C22H22BrP (396.06424020000003)
N,N-diethyl-4-[(1-methylpyridin-1-ium-4-yl)diazenyl]aniline,iodide
5-((4-(2,3-DIHYDROTHIENO[3,4-B][1,4]DIOXIN-5-YL)QUINOLIN-6-YL)METHYLENE)THIAZOLIDINE-2,4-DIONE
C19H12N2O4S2 (396.02384720000003)
4-iodo-N-(2-morpholin-4-ylethyl)benzenesulfonamide
2-BENZYLOXY-5-BROMO-BENZOIC ACID BENZYL ESTER
C21H17BrO3 (396.03609919999997)
2-(1-oxonaphtho[2,1-b]thien-2(1H)-ylidene)naphtho[2,1-b]thiophen-1(2H)-one
3-(2-Benzyloxy-5-bromo-phenyl)-3-phenyl-propan-1-ol
Calcium cyclamate
D000074385 - Food Ingredients > D005503 - Food Additives D010592 - Pharmaceutic Aids > D005421 - Flavoring Agents
TERT-BUTYL 6-BROMO-4-OXO-3,4-DIHYDRO-1H-SPIRO[1,3-BENZOXAZINE-2,4-PIPERIDINE]-1-CARBOXYLATE
C17H21BrN2O4 (396.06846060000004)
3-[(E)-3-anilino-3-oxoprop-1-enyl]-4,6-dichloro-1H-indole-2-carboxylic acid
C18H11Cl2N2NaO3 (396.00443960000007)
3,5-bis(4-Nitrophenoxy)benzoic acid
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Phosphonium,3-buten-1-yltriphenyl-, bromide (1:1)
C22H22BrP (396.06424020000003)
METHYL (S)-2-(BOC-AMINO)-3-(5-BROMO-3-INDOLYL)PROPANOATE
C17H21BrN2O4 (396.06846060000004)
5,6-Dihydro-6-(3-methoxypropyl)-4-(propylamino)-4H-thieno(2,3-b)thiopyran-2-sulfonamide 7,7-dioxide
3-(4-Fluorophenoxy)-6-methoxy-2-(4-methoxyphenyl)-1-benzothiophene 1-oxide
4-[(1,3-Dioxo-5-benzo[de]isoquinolinyl)sulfonylamino]benzoic acid
C19H12N2O6S (396.04160520000005)
Zinc;[amino-[2-[[5-[amino(azaniumylidene)methyl]benzimidazol-1-id-2-yl]methyl]benzimidazol-1-id-5-yl]methylidene]azanium
methyl (1R,2R)-2,5,7-trihydroxy-2-methyl-4,6,11-trioxo-1,3-dihydrotetracene-1-carboxylate
2-Amino-4-(2-chlorophenyl)-6-[(4-chlorophenyl)thio]pyridine-3,5-dicarbonitrile
C19H10Cl2N4S (396.00032000000004)
3-(2,4-dimethoxyphenyl)-6-phenyl-2-sulfanylidene-1H-thieno[2,3-d]pyrimidin-4-one
2-[(4-Chlorophenyl)sulfonyl-methylamino]acetic acid (2-anilino-2-oxoethyl) ester
C17H17ClN2O5S (396.05466620000004)
N-[4-methyl-5-[2-(4-methylanilino)-4-thiazolyl]-2-thiazolyl]-2-furancarboxamide
C19H16N4O2S2 (396.07146359999996)
2-[[5-(1H-benzimidazol-2-yl)-2-pyridinyl]thio]-N-(5-ethyl-1,3,4-thiadiazol-2-yl)acetamide
C18H16N6OS2 (396.08269659999996)
N-[3-[(4-chlorophenyl)-oxomethyl]-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]-3-pyridinecarboxamide
2-[(5-chloro-2-thiophenyl)sulfonylamino]-N-(2-furanylmethyl)benzamide
C16H13ClN2O4S2 (396.00052480000005)
1-[2-Furanyl(oxo)methyl]-6-(1-pyrrolidinylsulfonyl)-2-benzo[cd]indolone
5-bromo-N-[2-(4-fluorophenyl)-2-(4-morpholinyl)ethyl]-2-furancarboxamide
C17H18BrFN2O3 (396.04847499999994)
2,4-diamino-10-(2-chlorophenyl)-5-imino-8-oxo-7,8,9,10-tetrahydro-5H-thiopyrano[2,3-b:4,5-b]dipyridine-3-carbonitrile
C18H13ClN6OS (396.05600380000004)
(6R,7S)-3-(acetyloxymethyl)-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
2-Bromo-1-(4-methoxyphenyl)-3-[(4-methylphenyl)sulfonyl]-1-propanone
C17H17BrO4S (396.00308620000004)
5-(3-Methoxyphenyl)-1-(5-methyl-1,2-oxazol-3-yl)-4-(thiophene-2-carbonyl)pyrrolidine-2,3-dione
[3-(3,5,7-Trihydroxy-6-methoxy-4-oxochromen-2-yl)phenyl] hydrogen sulate
2,3,4,6,7-Pentaacetoxy-2,4,6-cycloheptatrien-1-one
Cephalothin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
sulconazole
C18H15Cl3N2S (396.00214800000003)
D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use > D01AC - Imidazole and triazole derivatives D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent
[4,5-Dihydroxy-9,10-dioxo-3-(3-oxopentanoyl)-9,10-dihydroanthracen-2-yl]acetic acid
Nogalaviketone
A methyl ester derived from (1R,2S)-2,5,7-trihydroxy-2-methyl-4,6,11-trioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylic acid.
4-de(dimethylamino)-4-oxoanhydrotetracycline(1-)
An organic anion that is the conjugate base of 4-dedimethylamino-4-oxoanhydrotetracycline, obtained by deprotonation of the 2-hydroxy group. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
Cefalotin
A semisynthetic, first-generation cephalosporin antibiotic with acetoxymethyl and (2-thienylacetyl)nitrilo moieties at positions 3 and 7, respectively, of the core structure. Administered parenterally during surgery and to treat a wide spectrum of blood infections.
Gavestinel (sodium salt)
C18H11Cl2N2NaO3 (396.00443960000007)
Gavestinel (GV 150526A) is a potent, selective, orally active and non-competitive antagonist of NMDA receptor. Gavestinel binds to the glycine site of the NMDA receptor, with a pKi of 8.5. Gavestinel can be used for the research of acute ischemic stroke[1].
PIT
PIT (2,2'-Pyridylisatogen tosylate) is a selective and non-competitive antagonist of P2Y1 receptor with an IC50 value of 0.14 μM for human P2Y1 receptor. PIT antagonizes P2Y1 receptor signaling without affecting nucleotide binding. PIT is an irreversible antagonist of responses to ATP at metabotropic purinoceptors (of the P2Y family) in some smooth muscles. PIT can be used for the research of chronic bronchitis and asthma[1][2][3].
5,13-dichloro-14-hydroxy-6-methoxy-4,7,12-trimethyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-15-carbaldehyde
10-hydroxy-16-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,12-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8,10,15-pentaen-14-one
13,15-dichloro-5,14-dihydroxy-7,12-dipropyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one
C19H18Cl2O5 (396.05312380000004)
2-(2h-1,3-benzodioxol-5-yl)-3,5,6-trimethoxyfuro[2,3-h]chromen-4-one
7,10,15-trihydroxy-2,4,17-trimethyl-13,20-dioxapentacyclo[10.8.0.0²,⁹.0³,⁷.0¹⁴,¹⁹]icosa-1(12),4,9,14,16,18-hexaene-6,8,11-trione
5,8-bis(acetyloxy)-6-methyl-9,10-dioxoanthracen-1-yl acetate
anthraxin
{"Ingredient_id": "HBIN016298","Ingredient_name": "anthraxin","Alias": "NA","Ingredient_formula": "C21H16O8","Ingredient_Smile": "CC(CC1=CC(=O)C2=C(O1)C=C(C3=C2OC(=CC3=O)C4=CC(=C(C=C4)O)O)O)O","Ingredient_weight": "396.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1371","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101515731","DrugBank_id": "NA"}
5,15-dichloro-6,14-dihydroxy-4,12-dipropyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
C19H18Cl2O5 (396.05312380000004)
(3s,6r)-6-bromo-6-[(2s,5r)-5-bromo-2,6,6-trimethyloxan-2-yl]-3-methylhex-1-en-3-ol
[(2r,3s,4s,5r,6s)-6-(3,4-dimethoxyphenoxy)-3,4,5-trihydroxyoxan-2-yl]methoxysulfonic acid
(7r)-7-methyl-6,8-dioxo-3-[(1e)-3-oxoprop-1-en-1-yl]isochromen-7-yl 2,4-dihydroxy-6-methylbenzoate
3-[2-(3,4-dihydroxyphenyl)ethenyl]-8,9-dihydroxy-6-methoxy-6h-pyrano[4,3-c]isochromen-1-one
(2s,6'r)-7-bromo-2',4,6-trimethoxy-6'-methylspiro[1-benzofuran-2,1'-cyclohexan]-2'-ene-3,4'-dione
{3,4,5-trihydroxy-6-[2-hydroxy-5-(2-hydroxyethyl)phenoxy]oxan-2-yl}methoxysulfonic acid
methyl 4-chloro-2-hydroxy-3-[3-hydroxy-2-(methoxycarbonyl)-5-methylphenoxy]-5-methoxybenzoate
7-(4-carboxybuta-1,3-dien-1-yl)-2,5,8-trihydroxy-9,10-dioxophenanthrene-3-carboxylic acid
2-[2-chloro-5-hydroxy-6-(methoxycarbonyl)-3-methylphenoxy]-3,5-dimethoxybenzoic acid
4-[5,7-bis(acetyloxy)-4-oxochromen-3-yl]phenyl acetate
methyl 3-chloro-2-hydroxy-6-[4-hydroxy-2-methoxy-6-(methoxycarbonyl)phenoxy]-4-methylbenzoate
[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[2-hydroxy-5-(2-hydroxyethyl)phenoxy]oxan-2-yl]methoxysulfonic acid
2,3,5,6,7-pentachloropentadec-14-en-4-ol
C15H25Cl5O (396.03479500000003)
16-hydroxy-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8,10,15-pentaen-12-one
methyl 3-chloro-6-hydroxy-2-[4-hydroxy-2-methoxy-6-(methoxycarbonyl)phenoxy]-4-methylbenzoate
methyl 4-chloro-3-hydroxy-2-[3-hydroxy-2-(methoxycarbonyl)-5-methylphenoxy]-5-methoxybenzoate
13,15-dichloro-6,14-dihydroxy-4,12-dipropyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one
C19H18Cl2O5 (396.05312380000004)
[5,6-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxochromen-7-yl]oxidanesulfonic acid
(6r)-3-[(1e)-2-(3,4-dihydroxyphenyl)ethenyl]-8,9-dihydroxy-6-methoxy-6h-pyrano[4,3-c]isochromen-1-one
7-[(1e,3e)-4-carboxybuta-1,3-dien-1-yl]-2,5,8-trihydroxy-9,10-dioxophenanthrene-3-carboxylic acid
7-bromo-2',4,6-trimethoxy-6'-methylspiro[1-benzofuran-2,1'-cyclohexan]-2'-ene-3,4'-dione
(3s,6r)-6-bromo-6-[(2s,5s)-5-bromo-2,6,6-trimethyloxan-2-yl]-3-methylhex-1-en-3-ol
5,7-dihydroxy-13-methoxy-3,11,21,22-tetraoxaheptacyclo[10.9.1.1¹,⁶.1¹²,¹⁶.0²,⁴.0¹⁰,²⁴.0²⁰,²³]tetracosa-6(24),7,9,16,18,20(23)-hexaen-15-one
6-bromo-6-(5-bromo-2,6,6-trimethyloxan-2-yl)-3-methylhex-1-en-3-ol
(2r,3s,4r,5s,6s,7r)-2,3,5,6,7-pentachloropentadec-14-en-4-ol
C15H25Cl5O (396.03479500000003)